Sunshine Biopharma Warrant Stock Technical Analysis

SBFMW Stock  USD 0.09  0.07  43.06%   
As of the 18th of May 2024, Sunshine Biopharma has the Coefficient Of Variation of 1278.38, semi deviation of 20.14, and Risk Adjusted Performance of 0.0556. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Sunshine Biopharma, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We have collected data for nineteen technical drivers for Sunshine Biopharma Warrant, which can be compared to its competition. Please validate Sunshine Biopharma variance and potential upside to decide if Sunshine Biopharma is priced more or less accurately, providing market reflects its prevalent price of 0.0911 per share. As Sunshine Biopharma appears to be a penny stock we also recommend to double-check its total risk alpha numbers.

Sunshine Biopharma Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Sunshine, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Sunshine
  
Sunshine Biopharma's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Sunshine Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Sunshine Biopharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Sunshine Biopharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Sunshine Biopharma Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Sunshine Biopharma volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Sunshine Biopharma Trend Analysis

Use this graph to draw trend lines for Sunshine Biopharma Warrant. You can use it to identify possible trend reversals for Sunshine Biopharma as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Sunshine Biopharma price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Sunshine Biopharma Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Sunshine Biopharma Warrant applied against its price change over selected period. The best fit line has a slop of   0.0007  , which means Sunshine Biopharma Warrant will continue generating value for investors. It has 122 observation points and a regression sum of squares at 0.02, which is the sum of squared deviations for the predicted Sunshine Biopharma price change compared to its average price change.

About Sunshine Biopharma Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Sunshine Biopharma Warrant on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Sunshine Biopharma Warrant based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Sunshine Biopharma price pattern first instead of the macroeconomic environment surrounding Sunshine Biopharma. By analyzing Sunshine Biopharma's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Sunshine Biopharma's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Sunshine Biopharma specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2021 2022 2023 2024 (projected)
Payables Turnover2.740.956.156.46
Days Of Inventory On Hand327.27453.31131.62125.04

Sunshine Biopharma May 18, 2024 Technical Indicators

Most technical analysis of Sunshine help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Sunshine from various momentum indicators to cycle indicators. When you analyze Sunshine charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Sunshine Biopharma May 18, 2024 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Sunshine stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
When determining whether Sunshine Biopharma is a strong investment it is important to analyze Sunshine Biopharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Sunshine Biopharma's future performance. For an informed investment choice regarding Sunshine Stock, refer to the following important reports:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sunshine Biopharma Warrant. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
For more information on how to buy Sunshine Stock please use our How to Invest in Sunshine Biopharma guide.
You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Complementary Tools for Sunshine Stock analysis

When running Sunshine Biopharma's price analysis, check to measure Sunshine Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sunshine Biopharma is operating at the current time. Most of Sunshine Biopharma's value examination focuses on studying past and present price action to predict the probability of Sunshine Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sunshine Biopharma's price. Additionally, you may evaluate how the addition of Sunshine Biopharma to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Is Sunshine Biopharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sunshine Biopharma. If investors know Sunshine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sunshine Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.21)
Revenue Per Share
99.017
Quarterly Revenue Growth
0.949
Return On Assets
(0.11)
Return On Equity
(0.21)
The market value of Sunshine Biopharma is measured differently than its book value, which is the value of Sunshine that is recorded on the company's balance sheet. Investors also form their own opinion of Sunshine Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Sunshine Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sunshine Biopharma's market value can be influenced by many factors that don't directly affect Sunshine Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sunshine Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sunshine Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sunshine Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.